Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity

Molecular Endocrinology

Volumn 10, Issue 12, 1996, Pages 1605-1616

  Norris, John D ^a   Fan, Daju ^a   Wagner, Brandee L ^a   McDonnell, Donald P ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN; TRANSCRIPTION FACTOR AP 1; VITELLOGENIN;

ARTICLE; BINDING SITE; DELETION MUTANT; DNA BINDING; DRUG POTENTIATION; ENHANCER REGION; GENE TRANSFER; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; TRANSCRIPTION REGULATION;

BINDING SITES; COMPLEMENT C3; ELECTROPHORESIS; ENHANCER ELEMENTS (GENETICS); ESTRADIOL; ESTROGEN ANTAGONISTS; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; TAMOXIFEN; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION;

MAMMALIA;

EID: 0029856633     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.10.12.1605     Document Type: Article

References (39)

1. Juan TS, Wilson DR, Wilde MD, Darlington GJ 1993 Participation of the transcription factor C/EBPγ in the acute-phase regulation of the human gene for complement component C3. Proc Natl Acad Sci USA 90:2584-2588
2. Kawamura N, Singer L, Wetsel RA, Colten HR 1992 Cis- and trans-acting elements required for constitutive and cytokine-regulated expression of the mouse complement C3 gene. Biochem J 283:705-712
3. Darlington GJ, Wilson DR, Lachman LB 1986 Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 103:787-793
4. Barnum SR, Fey G, BFT 1989 Biosynthesis and Genetics of C3. Curr Top Microbiol Immunology 153:23-43
5. Sundstrom SA, Komm BS, Xu Q, Boundy V, Lyttle CR 1990 The stimulation of uterine complement component C3 gene expression by antiestrogens. Endocrinology 126:1449-1456
6. Ace CI, Okulicz WC 1995 Differential gene regulation by estrogen and progesterone in the primate endometrium. Mol Cell Endocrinol 115:95-103
7. Hasty LA, lambris JD, Lessey BA, Pruksananonda K, Lyttle CR 1994 Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am J Obstet Gynecol 170:168-175
8. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transcriptional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
9. Smith DF, Toft DO 1993 Steroid receptors and their associated proteins. Mol Endocrinol 7:4-11
10. Beekman JM, Alan GF, Tsai SY, Tsai M, O'Malley BW 1993 Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol 7:1266-1274
11. McDonnell DP, Nawaz Z, O'Malley BW 1991 In Situ Distinction between steroid receptor binding and transactivation at a target gene. Mol Cell Biol 11:4350-4355
12. Kumar V, Chambon P 1988 The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145-156
13. McDonnell DP, Lieberman BA, Norris J 1995 Development of tissue-selective estrogen receptor modulators. In: Baird DT, Schutz G, Krattenmacher R (eds) Organ-Selective Actions of Steroid Hormones. Springer-Verlag, Berlin, vol 16:1-28
14. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
15. Blobel GA, Sieff CA, Orkin SH 1995 Ligand-dependent repression of the erythoid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 15:3147-3153
16. Stein B, Yang M 1995 Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kB and C/EBPb. Mol Cell Biol 15:4971-4979
17. Sukovich DA, Mukherjee R, Benfield PA 1994 A novel, cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element. Mol Cell Biol 14:7134-7143
18. Elgort MG, Zou A, Marschke KB, Allegretto EA 1996 Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic adic receptor-a-1 promoter via a novel sequence. Mol Endocrinol 10:477-487
19. McDonnell DP, Clemm DL, Herman T, Goldman ME, Pike JW 1995 Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
20. Vik DP, Amiguet P, Moffat GJ, Fey M, Amiguet-Barras F, Wetsel RA, Tack BF 1991 Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence. Biochemistry 30:1080-1085
21. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM 1988 Induction of proto-oncogene JUN/AP1 by serum and TPA. Nature 334:629-31
22. Klein-Hitpass L, Ryffel GU, Heitlinger E, Cato ACB 1988 A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res 16:647-663
23. Aronica SM, Kraus WL, Katzenellenbogen BS 1994 Estrogen action via the cAMP signalling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521
24. Norris J, Fan D, Aleman C, Marks JR, Futreal PA, Wiseman RW, Iglehart JD, Deininger PL, McDonnell DP 1995 Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 270:22777-22782
25. Klein-hitpass L, Schropp M, Wagner U, Ryffel GU 1986 An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053-1061
26. Klein-Hitpass L, Kaling M, Ryffel GU 1988 Synergism of closely adjacent estrogen-responsive elements increases their regulatory potential. J Mol Biol 201:537-544
27. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
28. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL 1992 Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852-856
29. Gottardis MM, Robinson SP, Jordan VC 1988 Estradiol-stimulated growth of MCF-7 tumors implanted in athymic nude mice: a model to study the tumoristatic action of tamoxifen. J Steroid Biochem 30:311-314
30. Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, Cambell S 1994 Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318-1321
31. Gaub M, Bellard M, Scheuer I, Chambon P, Sassone-Corsi P 1990 Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex. Cell 63:1267-1276
32. Berry M, Metzgar D, Chambon P 1990 Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818
33. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M 1994 Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458
34. Cavaillès V, Dauvois S, Danielian PS, Parker MG 1994 Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013
35. Onate SA, Tsai S, Tsai M-J, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
36. Hollenberg SM, Giguère V, Segui P, Evans RM 1987 Co-localization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49:39-46
37. Horton RM, Pease LR 1991 Recombination and Mutagenesis of DNA Sequences Using PCR. IRL Press at Oxford Press, New York
38. MacGregor GR, Caskey CT 1989 Construction of plasmids that express E. coli B-galactosidase in mammalian cells. Nucleic Acids Res 17:2365
39. Dana SL, Hoener PA, Wheeler DA, Lawrence CB, Mc-Donnell DP 1994 Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Mol Endocrinol 8:1193-1207